LNC
IDXX icon

Lincoln National Corp’s Idexx Laboratories IDXX Stock Holding History

Lincoln National Corp’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-757
Closed -$409K – 550
2024
Q1 		$409K Buy
757
+80
+12% +$43.7K 0.01% 831
2023
Q4 		$376K Sell
677
-37
-5% -$17.4K 0.01% 783
2023
Q3 		$312K Sell
714
-4,619
-87% -$2.3M 0.01% 768
2023
Q2 		$2.68M Sell
5,333
-260
-5% -$125K 0.05% 199
2023
Q1 		$2.8M Buy
5,593
+4,817
+621% +$2.31M 0.06% 187
2022
Q4 		$317K Buy
+776
New +$301K 0.01% 687
2020
Q4 		– Sell
-1,418
Closed -$557K – 764
2020
Q3 		$557K Buy
1,418
+14
+1% +$5.18K 0.02% 360
2020
Q2 		$464K Hold
1,404
– – 0.01% 389
2020
Q1 		$340K Hold
1,404
– – 0.01% 416
2019
Q4 		$367K Buy
+1,404
New +$370K 0.01% 452

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lincoln National Corp's IDXX Position: Q2 2024 in Review

Lincoln National Corp sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 757 shares — an estimated $409K sold.

Lincoln National Corp first reported a position in IDXX in Q4 2019 and held it in 10 quarters. The position peaked at $2.8M in Q1 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Lincoln National Corp reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 757 Idexx Laboratories shares in Q2 2024, an estimated $409K.
  • Lincoln National Corp first reported a position in Idexx Laboratories in Q4 2019 and held it in 10 quarters.
  • Lincoln National Corp's Idexx Laboratories position peaked at $2.8M in Q1 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.